×

Incyte CEO: We're building for the long term

12:47 PM ET Mon, 5 Dec 2016

Incyte president & CEO Herve Hoppenot speaks to CNBC's Meg Tirrell about the growth of bone marrow drug Jakafi, drug pricing under Donald Trump and the company's drug pipeline.